Key facts
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Corcillum
- ·The full record, as it builds
Funding rounds
No funding rounds for Corcillum are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Corcillum
Developer of cardiovascular diagnostic and analytics technology designed for improving the detection and management of heart disease. The company's platform integrates functional coronary modelling, artificial intelligence-powered analytics, and advanced medical technology to deliver faster diagnoses, more accurate imaging, and enhanced data workflows for healthcare professionals, enabling the medical sector to achieve improved cardiovascular outcomes and support the prevention of heart attacks.
- Sector
- Healthcare
- HQ
- Adelaide, Australia
- Founded
- 2022
- Employees
- 9
- Website
- corcillum.com.au/
- Ownership
- Privately Held (backing)
Corcillum doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Corcillum shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Corcillum in its N-PORT filings yet. We sweep new filings monthly.